Pre-filled Syringe Version of GSK’s Shingles Vaccine Approved by FDA
On July 17, 2025, officials at the U.S. Food and Drug Administration (FDA) granted a license to GSK plc (formerly GlaxoSmithKline) to distribute a pre-filled syringe version of Shingrix (Zoster Vaccine Recombinant Adjuvanted) vaccine to control outbreaks of shingles (herpes zoster) in adults. The pre-filled syringe version of Shingrix was approved for use by adults […]